HLA-B and COVID-19: Results obtained from the allelic group‐level analysis under a dominant model adjusted for age and genetic ancestry (Tables 2 and S2) suggested increased risk of severe COVID‐19 among carriers of the HLA Class I allele group HLA‐B*39 (OR = 3.26; 95% CI = [1.16–9.13]; p = 0.024) and the HLA Class II allele HLA‐DPB1*13 (OR = 3.42, 95% CI = [1.05–11.16]; p = 0.041).